Family · Pharmaceutical analytical standards
Epirubicin
An anthracycline anticancer drug described in Italy in 1975 by Federico Arcamone's group: it differs from doxorubicin only in the orientation of one hydroxyl group on the sugar. It is used mainly in breast cancer. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Its family descends from a red pigment made by Streptomyces peucetius, a bacterium isolated in the 1950s from a soil sample collected near Castel del Monte, in Apulia.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
